Nozer Mehta, VP, Biological R&D at UNIGENE LABORATORIES INC (UGNE), bought 1,400 shares at $0.54 ($756) on 2011-12-21, disclosed to the SEC on 2011-12-22.
Open-market purchase of $756 UGNE by VP, Biological R&D. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.